FdaApplication
ANDA 202671
Identifiers
- fda_app_no: ANDA202671
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2014-09-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IBANDRONATE SODIUM | IBANDRONATE SODIUM | EQ 3MG BASE/3ML | INJECTABLE;INTRAVENOUS |
1 product